Enoxaparin Sodium Injection, USP 120 mg/ 0.8 mL Single Dose Syringes with Automatic Safety Device...

FDA Drug Recall #D-0262-2021 — Class I — February 2, 2021

Recall Summary

Recall Number D-0262-2021
Classification Class I — Serious risk
Date Initiated February 2, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Apotex Corp.
Location Weston, FL
Product Type Drugs
Quantity 6832 cartons

Product Description

Enoxaparin Sodium Injection, USP 120 mg/ 0.8 mL Single Dose Syringes with Automatic Safety Device For Subcutaneous Injection 10 x 0.8 mL Single Dose Syringes Rx Only,Manufactured by: Gland Pharma Ltd. Hyderabad, India Manufactured for: Apotex Corp. Weston, FL 33326 NDC 60505-0796-4 UPC 360505079543 (carton) NDC 60505-0796-0 UPC (01)10360505079602 (label)

Reason for Recall

Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding to 120 mg/0.8mL strength)

Distribution Pattern

Nationwide

Lot / Code Information

Batch: CT003 Exp. 05/2022

Other Recalls from Apotex Corp.

Recall # Classification Product Date
D-0407-2026 Class II Brimonidine Tartrate/Timolol Maleate Ophthalmic... Mar 5, 2026
D-0676-2025 Class II Brimonidine Tartrate/Timolol Maleate Ophthalmic... Sep 5, 2025
D-0677-2025 Class II Ketorolac Tromethamine Ophthalmic Solution, 0.5... Sep 5, 2025
D-0457-2025 Class II Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL... May 28, 2025
D-0494-2025 Class II Ketorolac Tromethamine Ophthalmic Solution, 0.5... May 28, 2025

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.